Hindustan Unilever Limited has acquired the remaining 49% equity shareholding in Zywie Ventures Private Limited, which sells products under the OZiva brand, taking its total stake to 100%, for a cash consideration of ₹824 crore.
Anagram Partners and CMS IndusLaw advised Hindustan Unilever on this acquisition.
Anagram transaction team was led by Harman Walia (Partner) and consisted of Sanjana Mathur (Counsel), Tanmaya Negi (Prinicpal), Aman Gupta (Senior Associate) and Aditi Sinha (Associate).
CMS INDUSLAW also advised Hindustan Unilever on this acquisition.
The Firm's Corporate and IP teams advised the Company, with strategic inputs from Avimukt Dar (Founding & Senior Partner).
Corporate: Shivani Singh (Principal Associate), Rusha Ghosh Dastidar (Associate) and Prakhar Srivastava (Associate)
IP: Bharadwaj Jaishankar (Partner), Trushita Mehra (Senior Associate) and Ishita Goyal (Associate)
The firm had previously advised Hindustan Unilever on the initial 51% acquisition in Zywie.
Kaizen Law advised the Founder promoters Aarti Gill and Mihir Gadani on this transaction.
The transaction team was led by Harsh Kumar (Partner), with support from Utkarsh Nigam (Principal Associate) and Shalini Mishra (Associate).
First Principles Law advised exiting investors of OZiva, Eight Roads Ventures India III, F-Prime Capital Partners and Life Sciences Fund VI on this transaction.
Hindustan Unilever, one of India’s leading fast-moving consumer goods companies, had previously acquired a 51% stake in Zywie in 2023 as part of its strategic entry into the fast-growing Health & Wellbeing segment.
OZiva is an Indian plant-based nutrition and wellness brand focused on clean-label supplements for health, fitness, and overall well-being, blending modern nutrition with Ayurveda.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.